Categories AlphaGraphs, Earnings, Finance, LATEST

Charles Schwab Q4 2020 key financials and performance

The Charles Schwab Corporation (NYSE: SCHW) reported fourth-quarter 2020 earnings results today.

Net revenues year-over-year increased to $4.17 billion from $2.6 billion with a change of 60%. Analyst’s estimated total revenue of $4.11 billion.

GAAP net income increased to $1.13 billion from $852 million while EPS decreased to $0.57 from $0.62 per share. Adjusted net income to $1.45 billion while EPS increased 17% to $0.74 per share.  

CEO Walt Bettinger said, “The pandemic’s rapid escalation in early 2020 was accompanied by volatile equity markets and further easing of monetary policy. As the year progressed, government aid packages and vaccine developments helped settle the markets”.

The company reported a stock movement of positive 1% on Tuesday morning at a pre-market session, at $58.65.

  • Charles Schwab (SCHW) Q2 2020 Earnings AlphaGraph
  • Charles Schwab (SCHW) outclasses Q3 2019 earnings and revenue targets on strong client demand
  • Charles Schwab reports second quarter 2019 earnings results
  • Charles Schwab (SCHW) Q1 2019 earnings infograph

Most Popular

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings

Goldman Sachs (GS) stock research summary | Q3 2021

Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key

Add Comment
Viewing Highlight